A business partnership worth over a million dollars links companies half a world away, between Baltimore County and Australia. And before you read the rest of this article: No, “C-360” isn’t a typo where “B-360” should be. No dirtbikes were involved in this partnership.
Instead, Robotic Marketer, a software company with offices in South Yarra and Sydney, Australia (as well as an address in Atlanta, Georgia), recently entered an exclusive partnership with The C-360 Agency, a Sparks, Maryland-headquartered marketing, advertising and PR agency. Through this partnership, C-360 will serve as the exclusive US licensee for Robotic Marketer’s innovative strategy automation software in North America.
Robotic Marketer has developed a technology that a C-360 announcement called “the world’s first” artificial intelligence-based solution, integrating machine learning and big data to generate intricate marketing plans within minutes. C-360 CEO Mike DeMos told Technical.ly that this partnership will help the firm expand its business.
DeMos confirmed that the transcontinental partnership includes a significant investment of $1.1 million in marketing services. This licensing cost highlights the commitment to expanding Robotic Marketer’s presence and bringing marketing solutions to businesses throughout North America.
This partnership marks another milestone for Robotic Marketer, as the company already established exclusive licensing agreements with agencies in Australia, New Zealand and Malaysia.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

These 10 regions could be most impacted by federal return-to-office mandates

Tech-related orders and economic reorganizations hit Maryland. Here’s what they mean.

From Belgaum to Baltimore and beyond, this founder leaned on family to build a biotech juggernaut
